Prelude Capital Management, LLC Optimize Rx Corp Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$21.94 - $40.49 $304,636 - $562,203	13,885 New	13,885 $380,000
Q1 2020 May 15, 2020	SELL	$6.71 - $11.4 $16,781 - $28,511	-2,501 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.8 - $14.08 $1,188 - $1,900	-135 Reduced 5.12%	2,501 $26,000
Q3 2019 Nov 14, 2019	BUY	$13.6 - $16.96 $35,849 - $44,706	2,636 New	2,636 $38,000
Q1 2019 May 15, 2019	SELL	$10.74 - $15.59 $48,383 - $70,232	-4,505 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.45 - $17.82 $41,164 - $77,623	4,356 Added 2923.49%	4,505 $49,000
Q3 2018 Nov 14, 2018	BUY	$10.05 - $18.05 $1,497 - $2,689	149 New	149 $3,000

13.3M

79.8K

41.4K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $140M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.